论文信息 - Targeting pancreatic cancer by TAK-981: a SUMOylation inhibitor that activates the immune system and blocks cancer cell cycle progression in a preclinical model - 字舞流文

Targeting pancreatic cancer by TAK-981: a SUMOylation inhibitor that activates the immune system and blocks cancer cell cycle progression in a preclinical model

J. Rip | R. González-Prieto | A. Vertegaal | R. Arens | Jessie S. Kroonen | Sumit Kumar | T. van Hall | M. Verlaan-de Vries | M. Sluijter | N. D. de Miranda | L. Hawinkels | M. Schoonderwoerd | D. Ruano | Ilona J de Graaf | Ilona J. de Graaf | N. F. de Miranda